MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
about
The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisComparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.Novel biomarker candidates for the diagnosis of ovarian clear cell carcinomaDecreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinomaTumor protein D52 represents a negative regulator of ATM protein levels.Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of ChondrocytesNovel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
P2860
Q33745941-C20C791F-86B6-40A4-AEA0-3B81C046A37AQ33851325-D8861AA4-5CF4-43B7-B9F4-A53DFD08EDE3Q34356044-15DFFF15-ACAD-40E2-84B5-F7CAF933E153Q34764447-D6F5F0FB-73AB-47D2-866F-FB1ECE057BB9Q35871283-7C98ABC9-EC01-447A-B9B8-0D936DD81B6DQ36905913-E69BD979-24DD-4CE9-B214-0CE8BEF7A13EQ37420061-5B7BB6D7-1649-43C8-BBE8-44E523C41AE0Q40200300-EA065BFE-A719-41CC-ADD6-84497452AB67Q41180083-BB3149EB-A1AA-40E3-A5F1-EADC621B3673Q48300452-E8D30AA5-CA0F-46FF-BCD1-636F0B677E46Q54441612-F85D905A-C508-4C42-8CD0-28D8A1147E8C
P2860
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@ast
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@en
type
label
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@ast
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@en
prefLabel
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@ast
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@en
P2093
P2860
P50
P356
P1433
P1476
MAL2 and tumor protein D52 (TP ...... l subtype and patient outcome.
@en
P2093
Catherine Emmanuel
James P Scurry
Jayne R Hardy
Neville F Hacker
Philippa M O'Brien
Robert L Sutherland
Sanaz Maleki
P2860
P2888
P356
10.1186/1471-2407-10-497
P407
P577
2010-09-17T00:00:00Z
P5875
P6179
1037836967